Bayer stock heads into the open after a 1.9 percent Xetra gain
Published on 09/22/2026 at 07:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Bayer stock closed at EUR 49.03 on Xetra on September 21, 2026, gaining 1.95 percent from the prior session. The move came as the shares traded between an intraday low of EUR 47.98 and a high of EUR 49.26, while the broader DAX benchmark added about 1.07 percent on the same date.
September 21, 2026 in numbers
Bayer AG (ISIN DE000BAY0017) ended the last completed Xetra session at EUR 49.03 on September 21, 2026, up 1.95 percent versus its previous close according to the Xetra quote overview at Bolsamania. The same data set shows an intraday high of EUR 49.26 and a low of EUR 47.98 for the session, with the closing auction recorded at 18:30 in local time. On the index side, a European market summary from Newsweek Japan reported that the DAX closed at 25,575 points on September 21, 2026, up 270.95 points or 1.07 percent from its previous finish, so Bayer slightly outperformed the German blue-chip index in percent terms.
A separate Xetra closing wrap from Finanzen.ch noted that falling market interest rates supported German equities in general on September 21, 2026, which provided a favorable backdrop for Bayer shares during that session. In the context of the 52-week range reported by Investing.com for Bayer, which extends from EUR 25.78 to EUR 53.92 as of September 19, 2026, the September 21 close left the stock trading closer to the upper end of its one-year band, suggesting that the recent recovery has taken it well above its lows earlier in the year.
Today's drivers to watch
Today, Bayer heads into the open without a confirmed company-specific event dated September 22, 2026 in the available investor calendars, so broader market factors linked to interest rates and the performance of the DAX may again play an important role for the shares. The recent Xetra commentary from Finanzen.ch pointed out that declines in market yields have been supporting German equities, which is relevant for Bayer as a major DAX constituent. In addition, the one-year range highlighted by Investing.com shows where Bayer trades within its recent history as investors assess the balance between sector sentiment, interest rates and upcoming corporate news in the days ahead.
